Daily Archives: January 20, 2020

Mon January 20 – 10 Stories of The Day!

20 Jan, 2020 | 00:44h | UTC

 

1 – Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension – European Heart Journal – Cardiovascular Pharmacotherapy (free)

 

2 – AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis – Gastroenterology (free PDF)

Related: British Society of Gastroenterology Guidelines on the Management of Inflammatory Bowel Disease (guidelines on the subject)

 

3 – Lack of new antibiotics threatens global efforts to contain drug-resistant infections – World Health Organization (free)

See Reports: Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline – World Health Organization (free PDF) AND Antibacterial agents in preclinical development – World Health Organization (free PDF)

Commentary: W.H.O. Warns That Pipeline for New Antibiotics Is Running Dry – The New York Times (10 articles per month are free)

 

4 – Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Lack of Benefit of High-Dose Vitamin C, Thiamine, and Hydrocortisone Combination for Patients With Sepsis (free)

Conference Presentation: Effect of Vitamin C and Thiamine on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock (free)

Commentaries: JC: The Vitamins trial. Hydrocortisone, Vit C and Thiamine (Marik protocol – or not?) in sepsis – St Emlyn’s (free) AND Vitamin Treatment For Sepsis Fails In Large Trial – NPR (free) AND Metabolic Resuscitation: Was the answer inside us all along? – PulmCrit (free)

 

5 – Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial – JAMA (free)

Editorial: Proton Pump Inhibitors vs Histamine-2 Receptor Blockers for Stress Ulcer Prophylaxis in Critically Ill Patients: Issues of Interpretability in Pragmatic Trials (free for a limited period)

Conference Presentation: Effect of Stress Ulcer Prophylaxis With PPIs vs H2RBs on Mortality in Ventilated ICU Patients (free)

Commentaries: JC: The PEPTIC study PPI vs H2RBs on the ICU – St Emlyn’s (free) AND Risks And Benefits Of Proton Pump Inhibitors To Prevent Gi Bleeds In Intensive Care Patients – MedicalResearch.com (free)

 

6 – A review of cancer immunotherapy toxicity – CA: A Cancer Journal for Clinicians (free)

Related: Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)

 

7 – New Chinese virus ‘will have infected hundreds’ – BBC (free)

Original Analysis: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China – Imperial College London (free)

See also: As Thailand notes 2nd nCoV case, CDC begins airport screening – CIDRAP (free) AND China reports new virus cases, raising concern globally before key holiday – Reuters (free) AND China to step up countermeasures as virus outbreak grows – Reuters (free) AND China Reports New Cases of Deadly Virus, Adding to Fears of Outbreak – The New York Times (10 articles per month are free)

 

8 – The EVALI and Youth Vaping Epidemics — Implications for Public Health – New England Journal of Medicine (free)

See also: Update: Product, Substance-Use, and Demographic Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, August 2019–January 2020 – Centers for Disease Control and Prevention (free)

Related: CDC: Vaping Lung Illness Probably Caused by Vitamin E Acetate (free resources)

 

9 – 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT – Health Technology Assessment (free)

Original Article: 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial – The Lancet Oncology (free)

Source: EvidenceAlerts

 

10 – Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial – The Lancet (link to abstract – $ for full-text)

 

---